GB984114A - Controlled release compositions and their preparation - Google Patents

Controlled release compositions and their preparation

Info

Publication number
GB984114A
GB984114A GB16903/61A GB1690361A GB984114A GB 984114 A GB984114 A GB 984114A GB 16903/61 A GB16903/61 A GB 16903/61A GB 1690361 A GB1690361 A GB 1690361A GB 984114 A GB984114 A GB 984114A
Authority
GB
United Kingdom
Prior art keywords
polar solvent
therapeutic agent
aluminium salt
gel
cellulose acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB16903/61A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Strong Cobb Arner Inc
Original Assignee
Strong Cobb Arner Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Strong Cobb Arner Inc filed Critical Strong Cobb Arner Inc
Publication of GB984114A publication Critical patent/GB984114A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
GB16903/61A 1960-05-17 1961-05-09 Controlled release compositions and their preparation Expired GB984114A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2957560A 1960-05-17 1960-05-17
US106152A US3101293A (en) 1960-05-17 1961-04-28 Controlled release compositions and their preparation

Publications (1)

Publication Number Publication Date
GB984114A true GB984114A (en) 1965-02-24

Family

ID=26705096

Family Applications (1)

Application Number Title Priority Date Filing Date
GB16903/61A Expired GB984114A (en) 1960-05-17 1961-05-09 Controlled release compositions and their preparation

Country Status (6)

Country Link
US (1) US3101293A (cg-RX-API-DMAC10.html)
BE (1) BE603851A (cg-RX-API-DMAC10.html)
CH (1) CH448385A (cg-RX-API-DMAC10.html)
GB (1) GB984114A (cg-RX-API-DMAC10.html)
NL (1) NL264748A (cg-RX-API-DMAC10.html)
SE (1) SE327047B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242049A (en) * 1963-05-20 1966-03-22 Ncr Co Process for making enterically useful complex of spiramycin and product thereof
US3350270A (en) * 1964-09-18 1967-10-31 Leeds Dixon Lab Inc Aluminum aspirin film-enveloped therapeutic agents in sustained release dosage form
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
CN108272766B (zh) * 2018-03-21 2020-07-07 江苏四环生物制药有限公司 一种甲钴胺分散迟释片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2928769A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of controlled release medicaments
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition

Also Published As

Publication number Publication date
NL264748A (cg-RX-API-DMAC10.html)
BE603851A (fr) 1961-09-18
SE327047B (cg-RX-API-DMAC10.html) 1970-08-10
CH448385A (fr) 1967-12-15
US3101293A (en) 1963-08-20

Similar Documents

Publication Publication Date Title
US4722941A (en) Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
JP4020331B2 (ja) ガラス形成性担体に溶解した活性物質からなる組成物及びその製造方法
US4176179A (en) Method for treating arthritis
DE69206245T2 (de) Rifaximin enthaltendes Arzneimittel zur Behandlung von Vaginalinfektionen.
US3510561A (en) Sulfone-enhanced heparin absorption through mucous membranes
US4289751A (en) Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4202888A (en) Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
JPS63174922A (ja) 有効成分の投与のための医薬製剤
JPS61189230A (ja) エトポシド製剤
JPH0367045B2 (cg-RX-API-DMAC10.html)
US4692325A (en) Radiopaque medium
KR930005622A (ko) 레이슈마니아증을 치료하는데 경구 또는 국소 투여시키기 위한 약리학적 시약을 생산하는 방법
GB1005329A (en) Process for the preparation of sustained release pharmaceutical tablets
JPS5953410A (ja) 新型ソフトカプセル剤
SE327047B (cg-RX-API-DMAC10.html)
US5728403A (en) Coating technology for taste masking orally administered bitter drugs
US2566200A (en) Oral therapeutic tablets
KR101452721B1 (ko) 안정한 수성현탁액
DE2336807A1 (de) Darmloesliche kapseln
Fenn et al. Misoprostol—a logical therapeutic approach to gastroduodenal mucosal injury induced by non‐steroidal anti‐inflammatory drugs?
US2735798A (en) Acyl amevo-nitrothiazole compositions
JPS6024767B2 (ja) 腸溶性硬カプセル剤
LU80739A1 (de) Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
KR880002266B1 (ko) 종양 발육 억제 조성물
GB2061111A (en) Long acting pharmaceutical composition